AlzeCure Pharma

Activities: Drug Delivery Research & Development

Trending Articles

  1. Sanofi opens €558m modular vaccine and biologics manufacturing facility in Singapore The biopharmaceutical manufacturing facility will allow Sanofi to manufacture up to four vaccines and biologic medicines simultaneously, while also enhancing the area's...
  2. Pfizer appoints Chris Boshoff as Chief Scientific Officer and President of R&D Dr Boshoff will be responsible for overseeing and advancing Pfizer's R&D initiatives across all therapeutic areas
  3. Ingenza and HydRegen collaborate to optimise biomanufacturing sustainability The companies will work together to optimise and scale HydRegen's range of amine-based biocatalysts, which are more sustainable and cost-effective than traditional metal catalysts
  4. You need to be a subscriber to read this article.
    Click here to find out more.
    The new fight against diabetes and obesity Incretin mimetics administered by autoinjectors or pens enable significant weight reduction and offer an important way to combat obesity and prevent type 2 diabetes. As such,...
  5. IMed Consultancy helps Toby Orthopaedics navigate UK regulations Regulatory consultancy ensures compliance and confidence for Miami-based company

Upcoming event

CPhI Middle East

10–12 December 2024 | Conference | Riyadh, Saudi Arabia See all

Related Content

Training & Education

AlzeCure releases paper on Trk receptor modulation for Alzheimer's disease

The paper details the potential of Trk receptor modulation in treating neurological conditions such as Alzheimer's and Parkinson's disease
Research & Development

AlzeCure elect Dr Jan Lundberg as a new board member

Dr Lundberg has experience in leadership position in global pharmaceutical companies, including AstraZeneca and Eli Lilly

AlzeCure's Alzheimer's project NeuroRestore ACD856 granted an additional patent

ACD856 and other substances in the NeuroRestore platform stimulate several important signalling systems and signalling molecules in the brain such as BDNF and NGF
Manufacturing

AlzeCure Pharma receives patent for anti-Alzheimer's drug

ACD856 and other substances in the NeuroRestore platform stimulate several important signalling systems and signalling molecules in the brain
Subscribe now